Chai, C. S. (2018). P3. 15-21 Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer. Elsevier.
استشهاد بنمط شيكاغوChai, Chee Shee. P3. 15-21 Real-World Experience of First-Line Afatinib Treatment in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer. Elsevier, 2018.
MLA استشهادChai, Chee Shee. P3. 15-21 Real-World Experience of First-Line Afatinib Treatment in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer. Elsevier, 2018.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.